1. A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors. Avalible from: https://www.clinicaltrials.gov/ct2/show/NCT01962896.
2. A Study of Atezolizumab in Advanced Solid Tumors. Avalible from: https://www.clinicaltrials.gov/ct2/show/NCT02458638.
3. Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer research Network Study GU14-206;Adra;Ann. Oncol.,2018
4. Antitumor activity of brentuximab vedotin in CD30 positive refractory germ cell tumors;Albany;J. Clin. Oncol.,2013
5. Deregulation of the RB pathway in human testicular germ cell tumours: RB pathway defects in testicular cancer;Bartkova;J. Pathol.,2003